UTMD: Utah Med Projected Price to Earnings

Brandmark of Utah Medical Products (UTMD)

Utah Medical Products (UTMD) develops specialized devices for gynecology and neonatology, generating profit through the production of high-demand consumables with minimal management overhead. The company's price evolution demonstrates a current metric of 0.00, confirming the efficiency of this model. The business maintains stable global sales, as the medical specificity of its products ensures that exports remain independent of current interstate conflicts or trade restrictions.

UTMD - Utah Medical Products, Inc. Market Cap to Projected Earnings over the range 07/04/2022 - 11/16/2026

Analytical breakdowns and data insights for company Utah Medical Products, Inc. (UTMD)

- stock value and consensus price forecast:
Summary company analysis:UTMD Utah Medical
Signature product of utahmed.com

The asset's fundamental risks are determined by the ratio of market price to projected earnings. For Utah Medical Products (UTMD), which dominates the high-margin obstetric instrumentation niche, the stability of this valuation is critical. The company's forward P/E ratio compares the current share price with expected annual earnings. A discount on the chart indicates a margin of safety, while an overvaluation signals a correction risk. This allows for an assessment of whether the premium for the business's monopoly position is justified.

Direct competitors

Future Price to Earnings Intuitive Surgical Inc (ISRG)|DHR (Danaher Corp) - Future Price to Earnings Multiple|Forward P/E Multiple BDX (bd.com)|Market Cap to Projected Earnings steris.com (STE)|WST - Future Price to Earnings|BAX (Baxter International Inc.) - Price to Future Earnings Ratio|Masimo Corporation (MASI) - Future Price to Earnings|Price to Future Earnings Ratio STVN|Projected Price to Earnings TFX|Merit Medical (MMSI) - Market Cap to Projected Earnings|Projected Price to Earnings NVST (Envista Holdings)|Market Cap to Future Earnings Ratio ICUI|Future Price to Earnings Dentsply XRAY|Future Price to Earnings Multiple LMAT|ATRC: Projected Price to Earnings|STAA - Forward P/E Multiple|ChromaDex Corp (NAGE) - Future Price to Earnings|Projected Price to Earnings ZimVie|ANGO (angiodynamics.com) - Forward P/E Multiple|Projected Price to Earnings Ratio Cerus Inc CERS|Future Price to Earnings Teknova (TKNO)|Monogram Orthopedics - Price to Future Earnings Ratio|Sharps Technology - Projected Price to Earnings|Market Cap to Future Earnings Ratio INFU (InfuSystem Holdings)|KRMD - Future Price to Earnings|Market Cap to Projected Earnings Nyxoah S.A NYXH|microbotmedical.com (MBOT) - Future Price to Earnings|Price to Expected Earnings Ratio PDEX (pro-dex.com)|ZTEK (Zentek Corp) - Forward P/E Multiple|Future Price to Earnings ELUT|Future Price to Earnings Milestone Scientific Corp (MLSS)|NEXGEL, Inc - Price to Future Earnings Ratio|Forward P/E Multiple RVP (Retractable Technologies Inc.)|Harvard Bioscience, Inc. - Future Price to Earnings|FEMY - Future Price to Earnings|MHUA - Forward P/E Multiple|POAI: Forward P/E Multiple|Price to Future Earnings Ratio CJMB|Projected Price to Earnings ATRI|Projected Price to Earnings Ratio NeuroMetrix NURO